Australia markets open in 9 hours 14 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3600+0.0400 (+3.03%)
At close: 04:00PM EDT
1.3600 0.00 (0.00%)
After hours: 05:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.3200
Open1.3400
Bid1.1200 x 1000
Ask1.5400 x 2200
Day's range1.3300 - 1.3800
52-week range0.8600 - 3.0500
Volume43,588
Avg. volume680,266
Market cap51.826M
Beta (5Y monthly)1.32
PE ratio (TTM)36.76
EPS (TTM)0.0370
Earnings date27 June 2022 - 01 July 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date05 June 2015
1y target est4.00
  • GlobeNewswire

    Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test

    DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test throughout the European Union as well as other countries that recognise the CE Mark designation. In addition to its ease-of-use and impressive speed to result, in extensive clinical trails the test has demonstrated excellent 99% sensitiv

  • GlobeNewswire

    Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea

    DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has closed its recently announced strategic investment with the MiCo Group. Refinancing On Tuesday, May 3, 2022, the Company successfully closed an approximately $45 million strategic investment and partnership with MiCo Ltd (“MiCo”). MiCo, a KOSDAQ-listed and Korea-based co

  • GlobeNewswire

    Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results

    DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2021 and fiscal year 2021. Fiscal Year 2021 Results Total revenues for fiscal year 2021 were $93.0m compared to $102.0m in 2020, a decrease of 8.8% year on year and were broken down as follows: Full Year2020Full Year2021Increase/(decrease